Botox treatment is one of the most popular cosmetic treatments in the USA since being approved by the Federal Drug Administration (FDA) for the treatment of glabella wrinkles. In 2002 Botox injections were approved for cosmetic use after extensive clinical trials.
We was one of the first Botox injectors and has been on the forefront of facial injections in her New York City cosmetic dermatology practice for many years.
Botox was created by Allergan, an AbbVie company, and its indications for use and popularity have both increased exponentially over the years. Before Botox and other cosmetic injectables were invented, patients were forced to have invasive cosmetic procedures, such as facelifts and other plastic surgery for facial rejuvenation.
Botox was the first drug to use botulinum toxin. There are many other competitors now on the market including abobotulinumtoxinA (Dysport), rimabotulinumtoxinB (Myobloc), and incobotulinumtoxinA (Xeomin), prabotulinumtoxin-A (Jeuveau), and daxibotulinumtoxinA (Revance). Revance, the latest neurotoxin on the market, espouses a longer duration of activity of approximately six months.
Thanks to cosmetic injectables like Botox, Xeomin, Dysport, and other dermal filler products such as Sculptra, Restylane, and Juvederm Voluma, pan facial rejuvenation can be accomplished in a single treatment session. Botox was first developed and used by ophthalmologists to help treat poor eye muscle control.
Call us at (929) 571–385.